axio
Founded Year
2013Stage
Series G | AliveTotal Raised
$291.95MLast Raised
$19.9M | 2 mos agoRevenue
$0000Mosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+128 points in the past 30 days
About axio
axio specializes in consumer finance, offering a range of financial services including pay later options, credit facilities, and personal finance management. The company provides these services to individuals, focusing on accessibility and innovation to reach traditionally under-served consumer segments. axio operates as a Non-Banking Financial Company (NBFC) registered with the Reserve Bank of India, leveraging technology to streamline the financial product experience for its customers. It was founded in 2013 and is based in Bengaluru, India.
Loading...
Loading...
Research containing axio
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned axio in 3 CB Insights research briefs, most recently on Mar 15, 2022.
Mar 8, 2022 report
The 12 Industries Amazon Could Disrupt Next
Expert Collections containing axio
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
axio is included in 4 Expert Collections, including Fintech 100.
Fintech 100
748 items
250 of the most promising private companies applying a mix of software and technology to transform the financial services industry.
Digital Lending
2,271 items
This collection contains companies that provide alternative means for obtaining a loan for personal or business use and companies that provide software to lenders for the application, underwriting, funding or loan collection process.
SMB Fintech
1,231 items
Fintech
13,413 items
Excludes US-based companies
Latest axio News
Sep 20, 2024
News provided by Share this article Innovative biotech company now offers high-quality monoclonal antibody production to accelerate biologics development MADISON, Wis., Sept. 20, 2024 /PRNewswire/ -- Axio BioPharma, a trusted innovator and provider of high-quality recombinant proteins, is excited to announce that it is now accepting recombinant protein manufacturing projects. Located within Forward BIOLABS at 504 South Rosa Rd., Suite 200, Madison, WI, Axio BioPharma is poised to meet the growing demands of the biopharmaceutical industry. Axio BioPharma launches recombinant protein manufacturing, accelerating biopharma innovation. Axio BioPharma specializes in research-grade manufacturing of monoclonal antibodies (mAbs), focusing on small-scale production ranging from 50 mL to 2 L. The company's team of industry-leading experts is equipped to tackle unique program challenges, ensuring efficient and reliable results. In addition, Axio BioPharma supports mammalian-expressed proteins with scalable production capabilities. This flexibility allows the company to meet the needs of research and development programs, providing customized solutions that advance clients' biologics pipelines. Looking ahead, Axio BioPharma is committed to expanding its capabilities to better serve the biopharmaceutical community. GMP mammalian manufacturing capabilities are planned to be launched in early 2028. This strategic expansion will enable Axio BioPharma to support clients from early research stages all the way through clinical manufacturing, further accelerating the development of life-saving therapies. "By combining our expertise with flexible production scales, we are able to support our clients throughout various stages of their research and development," added Byers. "We understand the challenges in bringing new therapies to market, and we're here to make that process faster and more efficient. Our upcoming GMP services will allow us to provide even more comprehensive support to our clients." About Axio BioPharma Axio BioPharma is a Contract Development and Manufacturing Organization (CDMO) transforming biopharmaceutical manufacturing. Specializing in high-quality recombinant proteins, the company accelerates the development of mammalian-expressed proteins, with a focus on monoclonal antibodies (mAbs). Located in Madison, WI, Axio BioPharma is committed to reducing the time it takes to bring life-saving therapies to patients by being a preferred partner in the biopharma industry. For more information about Axio BioPharma and its services, please visit www.axiobiopharma.com or contact: Media Contact:
axio Frequently Asked Questions (FAQ)
When was axio founded?
axio was founded in 2013.
Where is axio's headquarters?
axio's headquarters is located at Bellary Road, Bengaluru.
What is axio's latest funding round?
axio's latest funding round is Series G.
How much did axio raise?
axio raised a total of $291.95M.
Who are the investors of axio?
Investors of axio include Amazon, Alteria Capital, Peak XV Partners, Lightrock, Creation Investments Capital Management and 18 more.
Who are axio's competitors?
Competitors of axio include Fundbox, MoneyView, Funding Societies, NeoGrowth, First Circle and 7 more.
Loading...
Compare axio to Competitors
Bluevine is a financial technology company that specializes in providing business banking solutions. The company offers business checking accounts with high-yield interest, accounts payable automation, and extensive FDIC insurance, as well as business loans and credit cards designed to meet the needs of small businesses. Bluevine primarily serves the small business sector with its suite of financial products. It was founded in 2013 and is based in Jersey City, New Jersey.
Fundbox provides an embedded working capital platform for small businesses, operating within the financial services industry. It offers services such as business loans and lines of credit, which are designed to help businesses manage their cash flow and cover expenses. It primarily serves the small business sector. The company was founded in 2013 and is based in San Francisco, California.
Funding Societies operates as a digital crowdfunding and financing platform for micro, small, and medium enterprises (MSMEs). It offers MSMEs access to capital without the need to put up collateral. The company also offers solutions besides lending, such as payments and collections, to help SMEs solve their cash flow management challenges. It was founded in 2015 and is based in Singapore.
First Circle is a fintech company specializing in providing non-collateral business loans to Small and Medium Enterprises (SMEs). The company offers a revolving credit line that businesses can access anytime for working capital needs, alongside other financial products designed to support business growth and project acquisition. First Circle primarily serves SMEs looking for accessible financing solutions to manage cash flow and fund expansion. It was founded in 2016 and is based in Taguig City, Philippines.
Kriya specializes in business-to-business payment solutions within the financial services sector. The company offers trade credit options for eCommerce checkouts, multichannel payment systems, and flexible invoice finance services to bridge cash flow gaps. Kriya primarily serves businesses looking to modernize their payment processes and their working capital management. Kriya was formerly known as MarketFinance. It was founded in 2011 and is based in London, United Kingdom.
Behalf is a financing provider that facilitates commerce between business to business vendors and their small and medium business customers. Driven by data and technology, Behalf allows vendor partners to offer business customers instant credit and flexible payment terms at the point of sale.
Loading...